- Home
- BZH vs IMTX Comparison
BZH vs IMTX Comparison
Compare BZH & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- IMTX
- Stock Information
- Founded
- BZH 1985
- IMTX N/A
- Country
- BZH United States
- IMTX Germany
- Employees
- BZH N/A
- IMTX N/A
- Industry
- BZH Homebuilding
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZH Consumer Discretionary
- IMTX Health Care
- Exchange
- BZH Nasdaq
- IMTX Nasdaq
- Market Cap
- BZH 591.6M
- IMTX 579.8M
- IPO Year
- BZH 1994
- IMTX N/A
- Fundamental
- Price
- BZH $20.53
- IMTX $5.39
- Analyst Decision
- BZH Strong Buy
- IMTX Strong Buy
- Analyst Count
- BZH 3
- IMTX 4
- Target Price
- BZH $37.00
- IMTX $14.67
- AVG Volume (30 Days)
- BZH 409.9K
- IMTX 626.4K
- Earning Date
- BZH 05-01-2025
- IMTX 05-13-2025
- Dividend Yield
- BZH N/A
- IMTX N/A
- EPS Growth
- BZH N/A
- IMTX N/A
- EPS
- BZH 3.10
- IMTX N/A
- Revenue
- BZH $2,436,131,000.00
- IMTX $155,801,989.00
- Revenue This Year
- BZH N/A
- IMTX N/A
- Revenue Next Year
- BZH $14.27
- IMTX $5.38
- P/E Ratio
- BZH $6.61
- IMTX N/A
- Revenue Growth
- BZH 13.50
- IMTX 93.56
- 52 Week Low
- BZH $17.37
- IMTX $3.30
- 52 Week High
- BZH $38.22
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- BZH 46.74
- IMTX 60.57
- Support Level
- BZH $20.20
- IMTX $4.93
- Resistance Level
- BZH $21.42
- IMTX $5.31
- Average True Range (ATR)
- BZH 0.78
- IMTX 0.37
- MACD
- BZH -0.19
- IMTX 0.05
- Stochastic Oscillator
- BZH 8.76
- IMTX 84.93
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.